Jump to content

Laura Rosella

Edit links
From Wikipedia, the free encyclopedia
Laura C. A. Rosella
Alma materUniversity of Toronto
Scientific career
InstitutionsUniversity of Toronto
ThesisA population based approach to diabetes mellitus risk prediction : methodological advances and practical applications. (2009)

Laura C. A. Rosella is a Canadian epidemiologist who is an Associate Professor at the Dalla Lana School of Public Health in the University of Toronto. She studies public health and the social determinants of health. Rosella holds a Canada Research Chair in Population Health Analytics.

Early life and education

[edit]

Rosella was an undergraduate student at the University of Toronto, where she majored in health science and epidemiology.[1] She remained at the University for her graduate studies, where she evaluated public health risk in people with diabetes mellitus.[2]

Research and career

[edit]

Rosella is a professor at the Dalla Lana School of Public Health at the University of Toronto.[3] Rosella is the Scientific Director of the Population Health Analytics Laboratory.[4] She has looked to prevent diabetes, through regular screenings and partnerships with provincial health ministries.[1] She developed DPoRT, a Diabetes Population Risk Tool which identifies the optimum cut offs for health screenings to prevent adverse medical outcomes.[5] At the same time, Rosella investigates how people living with diabetes accumulate chronic conditions. She combines her understanding of social and behavioural risk factor data with an understanding of healthcare utilisation to eliminate persistent health inequalities.[1]

From 2018 to 2022, she served as president of the Canadian Society for Epidemiology and Biostatistics.[6]

In November 2020, Rosella joined the Institute for Better Health as the Stephen Family Research Chair in Community Health.[7] In this capacity she looks to improve public health decision making and promote the equitable distribution of healthcare.[7] Rosella has evaluated the use of machine learning in predicting population health. She found that the majority of machine learning applications only made use of traditional data sources, and rarely used big data.[8]

Rosella served as a member of the Ontario COVID-19 Science Advisory Table as a part of the group's Modelling Consensus Table.[9]

Awards and honours

[edit]

Selected publications

[edit]
  • Jeffrey C Kwong; Kevin L Schwartz; Michael A Campitelli; et al. (1 January 2018). "Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection". The New England Journal of Medicine. 378 (4): 345–353. doi:10.1056/NEJMOA1702090. ISSN 0028-4793. PMID 29365305. Wikidata Q47549279.
  • Danuta M Skowronski; Gaston De Serres; Natasha S Crowcroft; et al. (6 April 2010). "Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada". PLOS MEDICINE. 7 (4): e1000258. doi:10.1371/JOURNAL.PMED.1000258. ISSN 1549-1277. PMC 2850386. PMID 20386731. Wikidata Q30388012.
  • Maria I Creatore; Richard H Glazier; Rahim Moineddin; et al. (1 May 2016). "Association of Neighborhood Walkability With Change in Overweight, Obesity, and Diabetes". JAMA. 315 (20): 2211–2220. doi:10.1001/JAMA.2016.5898. ISSN 0098-7484. PMID 27218630. Wikidata Q39740655.

References

[edit]
  1. ^ a b c "BBDC Member Profile". Banting & Best Diabetes Centre. 2019-01-07. Retrieved 2021-05-30.
  2. ^ Rosella, Laura C. A (2011). A population based approach to diabetes mellitus risk prediction: methodological advances and practical applications (Thesis). Ottawa: Library and Archives Canada = Bibliothèque et Archives Canada. OCLC 785764075.
  3. ^ "Rosella, Laura C." Dalla Lana School of Public Health. Retrieved 2021-05-30.
  4. ^ "Our Team". Population Health Analytics Laboratory | Toronto, ON. Retrieved 2021-05-30.
  5. ^ Rosella, Laura C.; Manuel, Douglas G.; Burchill, Charles; Stukel, Thérèse A.; PHIAT-DM team (July 2011). "A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT)". Journal of Epidemiology and Community Health. 65 (7): 613–620. doi:10.1136/jech.2009.102244. ISSN 1470-2738. PMC 3112365. PMID 20515896.
  6. ^ "Laura Rosella". University of Toronto. Retrieved 2024-08-21.
  7. ^ a b "IBH Welcomes New Research Chairs". Institute for Better Health. Retrieved 2021-05-30.
  8. ^ Morgenstern, Jason Denzil; Buajitti, Emmalin; O'Neill, Meghan; Piggott, Thomas; Goel, Vivek; Fridman, Daniel; Kornas, Kathy; Rosella, Laura C. (2020-10-27). "Predicting population health with machine learning: a scoping review". BMJ Open. 10 (10): e037860. doi:10.1136/bmjopen-2020-037860. ISSN 2044-6055. PMC 7592293. PMID 33109649.
  9. ^ "Our Partners". Ontario COVID-19 Science Advisory Table. Archived from the original on 2022-09-02. Retrieved 2022-09-02.
  10. ^ "PHO Scientist Wins Award from Canadian Society for Epidemiology and Biostatistics". Public Health Ontario. Archived from the original on 2021-06-02. Retrieved 2021-05-30.
  11. ^ "Past Award Winners – Early Career – Society for Epidemiologic Research". 18 June 2014. Retrieved 2021-05-30.
  12. ^ "Laura Rosella named a recipient of Canada's Top 40 Under 40". Dalla Lana School of Public Health. 2018-06-27. Retrieved 2021-05-30.
  13. ^ "Three Out of Five DLSPH Projects Earn Connaught Community Project Awards". Dalla Lana School of Public Health. 2020-09-25. Retrieved 2024-08-21.
  14. ^ "Laura Rosella". Canadian Institute for Advanced Research. 2023-07-09. Retrieved 2024-08-21.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Laura_Rosella&oldid=1241488997"